This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Reischig T, Jindra P, Hes O, Švecová M, Klaboch J, Třeška V.Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation. American Journal of Transplantation 8: 69-77, No. 1, Jan 2008
Rights and permissions
About this article
Cite this article
Preemptive vs prophylactic therapy for CMV disease prevention. Pharmacoecon. Outcomes News 549, 3 (2008). https://doi.org/10.2165/00151234-200805490-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805490-00007